Related Experiment Videos
Sleep deficits in rats after NMDA receptor blockade
W S Stone1, D L Walker, P E Gold
1Department of Psychology, University of Virginia, Charlottesville 22903.
Physiology & Behavior
|September 1, 1992
Summary
NPC 12626, an N-Methyl-D-aspartate (NMDA) receptor antagonist, disrupts sleep patterns in rats. Paradoxical sleep is particularly sensitive to NMDA receptor blockade, suggesting shared mechanisms for sleep and memory.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- N-Methyl-D-aspartate (NMDA) receptor blockade impairs neural plasticity, learning, and memory.
- Memory deficits correlate with reduced paradoxical sleep in amnesic populations.
Purpose of the Study:
- To investigate the effects of NPC 12626, an NMDA receptor antagonist, on sleep states in rats.
- To determine if NMDA receptor blockade specifically impacts paradoxical sleep.
Main Methods:
- Sprague-Dawley rats received NPC 12626 (1, 10, 50, 100 mg/kg) or saline.
- Sleep patterns were recorded for 3 hours during daytime periods post-administration.
Main Results:
- Paradoxical sleep was impaired by NPC 12626 at doses of 1, 10, and 50 mg/kg.
- Nonparadoxical sleep deficits emerged at 10 mg/kg and became prominent at 50 mg/kg.
- The highest dose (100 mg/kg) completely prevented sleep.
Conclusions:
- NPC 12626 disrupts both paradoxical and nonparadoxical sleep states in rats.
- Paradoxical sleep is highly susceptible to NMDA receptor blockade.
- These findings suggest shared neurobiological mechanisms for sleep and memory processes.